摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

phenylmethyl (S)-2-<<(1,1-dimethylethoxy)carbonyl>amino>-5-hexenoate | 141362-38-1

中文名称
——
中文别名
——
英文名称
phenylmethyl (S)-2-<<(1,1-dimethylethoxy)carbonyl>amino>-5-hexenoate
英文别名
Benzyl 2(S)-<(tert-butoxycarbonyl)amino>hex-5-enoate;benzyl (S)-2-((tert-butoxycarbonyl)amino)hex-5-enoate;benzyl (2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]hex-5-enoate
phenylmethyl (S)-2-<<(1,1-dimethylethoxy)carbonyl>amino>-5-hexenoate化学式
CAS
141362-38-1
化学式
C18H25NO4
mdl
——
分子量
319.401
InChiKey
POLPKBFYDHURKE-HNNXBMFYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    440.2±45.0 °C(Predicted)
  • 密度:
    1.069±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    23
  • 可旋转键数:
    10
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    64.6
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    phenylmethyl (S)-2-<<(1,1-dimethylethoxy)carbonyl>amino>-5-hexenoate 在 9-borabicyclo[3.3.1]nonane dimer 、 4 Angstroems MS 、 phosphorus pentoxide 、 1-羟基苯并三唑盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺pyridinium chlorochromate三氟乙酸 、 barium(II) oxide 作用下, 以 二氯甲烷N,N-二甲基甲酰胺 为溶剂, 反应 16.0h, 生成 phenylmethyl (2S)-1,2,3,4-tetrahydro-1-<carbonyl>-2-pyridinecarboxylate
    参考文献:
    名称:
    从常见的中间体合成血管紧张素转换酶抑制剂(-)-A58365A和(-)-A58365B。
    摘要:
    由亚基9和10合成了血管紧张素转化酶抑制剂(-)-A58365A(1)和(-)-A58365B(2),它们被偶联,并且将得到的各个酰胺17a,b转化。通过臭氧分解成醛18a,b,然后进行环脱水成酰胺19a,b。用锡烷处理有助于产生乙烯基锡烷20a,b,通过原甲酸酯化和臭氧分解从中产生酮22a,b。然后进行碱处理和氢解,得到(-)-A58365A(1)。中间体17a,b也通过硼氢化和氧化转化为醛26a,b,然后应用与(-)-A58365A相似的序列,以完成同类物(-)-的第一对映体特异性合成。 A58365B(2)。
    DOI:
    10.1021/jo9822941
  • 作为产物:
    参考文献:
    名称:
    Development of Macrocyclic Peptides Containing Epoxyketone with Oral Availability as Proteasome Inhibitors
    摘要:
    Macrocyclization has been frequently utilized for optimizing peptide or peptidomimetic-based compounds. In an attempt to obtain potent, metabolically stable, and orally available proteasome inhibitors, 30 oprozomib-derived macrocyclic peptides with structural diversity in their N-terminus and linker were successively designed and synthesized for structure- activity relationship (SAR) studies. As a consequence, the macrocyclic peptides with N-methyl-pyrazole (24p, 24x), imidazole (24t), and pyrazole (24v) as their respective N-termini exhibited favorable in vitro activity and metabolic stability, which translated into their potent in vivo proteasome inhibitory activity after oral administration. In particular, compound 24v, as the most distinguished one among this series, displayed excellent chymotrypsin-like (ChT-L, beta 5) inhibitory potency (IC50 = 16 nM), low nanomolar antiproliferative activity against all three of the tested cell lines, and superior metabolic stability in mouse liver microsome (MLM), as well as favorable inhibition against ChT-L compared to that of oprozomib in BABL/c mice following po administration at a comparatively low dose, thereby representing a promising candidate for further development.
    DOI:
    10.1021/acs.jmedchem.8b00819
点击查看最新优质反应信息

文献信息

  • Preparation of enantiomerically pure protected unsaturated α-amino acids from a new serine derived zinc–copper reagent
    作者:Michael J. Dunn、Richard F. W. Jackson
    DOI:10.1039/c39920000319
    日期:——
    Treatment of the iodoalanine derived zinc reagent 1 with Knochel's soluble copper salt (CuCN·2LiCl) allows the preparation of a reactive copper reagent 2 which couples in moderate to good yield with allyl halides to give protected unsaturated α-amino acids in a single step from easily available precursors.
    利用酸衍生的锌试剂1与Knochel可溶性盐(CuCN·2LiCl)处理,可制备出一种活性试剂2,该试剂与烯丙基卤化物在温和至良好的产率下偶联,可从易获得的起始物直接一步合成得到保护的不饱和α-氨基酸
  • Cross metathesis-mediated synthesis of hydroxamic acid derivatives
    作者:Shital Kumar Chattopadhyay、Subhankar Ghosh、Suman Sil
    DOI:10.3762/bjoc.14.285
    日期:——
    An alternative synthesis of α,ß-unsaturated hydroxamates via cross metathesis between a class-I olefin and N-benzyloxyacrylamide is reported. The reaction proceeds better in the presence of Grubbs' second generation catalyst within short time and in good yields (57-85%) with a range of substrates. Subsequent hydrogenation of each of the CM products delivers the title compounds in moderate to very good
    据报道,通过I类烯烃和N-苄氧基丙烯酰胺之间的交叉复分解,可以合成α,ß-不饱和异羟酸酯。在格拉布斯第二代催化剂的存在下,该反应在短时间内以多种底物在较高收率下(57-85%)更好地进行。随后,每种CM产品的氢化反应都会以中等至非常高的收率(70-89%)提供标题化合物。该协议的一个重要证明是生物活性环状肽Chap-31的异常氨基酸成分的制备。
  • Synthesis of Enantiomerically Pure Unsaturated .alpha.-Amino Acids Using Serine-Derived Zinc/Copper Reagents
    作者:Michael J. Dunn、Richard F. W. Jackson、Joerg Pietruszka、Debra Turner
    DOI:10.1021/jo00112a048
    日期:1995.4
    Treatment of the serine-derived organozinc reagent 2, in benzene/dimethylacetamide, with a THF solution of CuCN . 2LiCl gives rise to a zinc/copper reagent 6 which reacts directly with allylic halides and tosylates to give the corresponding enantiomerically pure substitution products 9 in 32-65% yield (11 examples). The reaction proceeds by formal S(N)2' displacement of the leaving group. Reaction with propargyl halides gives the corresponding terminal allene 12a. The zinc reagent 2 may also be prepared directly from protected iodoalanine 1 in THP by the Knochel method. Reaction with propargylic tosylates as electrophiles gives rise to the corresponding protected terminal allenic amino acids in 51-81% yield (four examples); use of enantiomerically enriched propargylic tosylates results in the formation of diastereoisomerically enriched allenic products. Reactions of the zinc/copper reagent 6 with a range of representative electrophiles is explored; use of relatively reactive electrophiles is necessary to obtain satisfactory yields. Finally, the possibility of using the serine-derived iodide 20, in which the carboxylic acid is protected as a methyl ester, is established: This reagent offers advantages over the corresponding benzyl ester protected reagent 6 for the synthesis of unsaturated amino acids.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸